Company profilePharmaceutical#541 of 1,318 in Pakistan✓ No DRAP alerts

Medimarker's Laboratories

Pharmaceutical company · 23 brands · 59 molecules

23 registered products 13 pharmaceutical brands 59 distinct molecules 0 DRAP alerts

Company overview

23
registered products
13
pharmaceutical brands
59
distinct molecules
0
therapeutic classes
0
DRAP alerts

Medimarker's Laboratories is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 23 product registrations across 59 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Medimarker's

11 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

10
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202610

Top molecules by brand count

Artemether2 brands
Sodium ...... 37.5 Mmol1 brand
Elemental Iron ...... 50 Mg1 brand
Chloride1 brand
Sodium Chloride ...... 1.75 Gm1 brand
Moxifloxacin ...... 0.5 % (W1 brand
Cefixime ...... 100 Mg1 brand
Cefixime ...... 200 Mg1 brand
Ciprofloxacin ...... 250 Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official42 products · Rs 57.83 – Rs 886.36
Median across source: Rs 340.69

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.26 shared molecules
FRIENDS PHARMA (PVT) LTD23 shared molecules
HIGH - Q INTERNATIONAL22 shared molecules
MEDISAVE PHARMACEUTICALS22 shared molecules
SCOTMANN PHARMACEUTICALS22 shared molecules
PEARL PHARMACEUTICALS21 shared molecules
IRZA PHARMA (PVT) LTD.21 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

MEDIATE PHARMACEUTICALS (PVT) LTD holds 107 molecules not in this portfolio
AcyclovirAlendronateAmlodipineAmoxicillinAmpicillinAmpicillin Base
BIO LABS (PVT) LTD. holds 135 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
GETZ PHARMA PAKISTAN (PVT) LTD. holds 269 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole

Get the full profile for Medimarker's

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.